Diaphragm dysfunction in heart failure is accompanied by increases in neutral sphingomyelinase activity and ceramide content

European Journal of Heart Failure

Volumn 16, Issue 5, 2014, Pages 519-525

  Empinado, Hyacinth M ^a   Deevska, Gergana M ^b   Nikolova Karakashian, Mariana ^b   Yoo, Jeung Ki ^a   Christou, Demetra D ^a   Ferreira, Leonardo F ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF KENTUCKY   (United States)

Author keywords

Dyspnoea; Force; Myocardial infarction; Skeletal muscle; Sphingolipids

Indexed keywords

CERAMIDE; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE; SPHINGOSINE 1 PHOSPHATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIAPHRAGM DISEASE; ENZYME ACTIVITY; FATIGUE; HEART FAILURE; HEART INFARCTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE STRENGTH; NONHUMAN; PRIORITY JOURNAL; RAT; ANIMAL; BIOLOGICAL MODEL; CHRONIC DISEASE; COMPLICATION; DIAPHRAGM; DISEASE MODEL; DYSPNEA; LEWIS RAT; METABOLISM; MUSCLE WEAKNESS; PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; CERAMIDES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CHRONIC DISEASE; DIAPHRAGM; DISEASE MODELS, ANIMAL; DYSPNEA; HEART FAILURE; ISOMETRIC CONTRACTION; MASS SPECTROMETRY; MODELS, CARDIOVASCULAR; MUSCLE WEAKNESS; MYOCARDIAL INFARCTION; RATS; RATS, INBRED LEW; SPHINGOMYELIN PHOSPHODIESTERASE;

EID: 84899470963     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1002/ejhf.73     Document Type: Article

References (36)

1. Meyer FJ, Borst MM, Zugck C, Kirschke A, Schellberg D, Kubler W, Haass M,. Respiratory muscle dysfunction in congestive heart failure: clinical correlation and prognostic significance. Circulation 2001; 103: 2153-2158.
2. van Hees HW, van der Heijden HF, Hafmans T, Ennen L, Heunks LM, Verheugt FW, Dekhuijzen PN,. Impaired isotonic contractility and structural abnormalities in the diaphragm of congestive heart failure rats. Int J Cardiol 2008; 128: 326-335.
3. van Hees HW, van der Heijden HF, Ottenheijm CA, Heunks LM, Pigmans CJ, Verheugt FW, Brouwer RM, Dekhuijzen PN,. Diaphragm single-fibre weakness and loss of myosin in congestive heart failure rats. Am J Physiol Heart Circ Physiol 2007; 293: H819-H828.
4. Dall'ago P, Chiappa GR, Guths H, Stein R, Ribeiro JP,. Inspiratory muscle training in patients with heart failure and inspiratory muscle weakness: a randomized trial. J Am Coll Cardiol 2006; 47: 757-763.
5. Del Rio R, Marcus NJ, Schultz HD,. Inhibition of hydrogen sulfide restores normal breathing stability and improves autonomic control during experimental heart failure. J Appl Physiol 2013; 114: 1141-1150.
6. Olson TP, Joyner MJ, Eisenach JH, Curry TB, Johnson BD,. Influence of locomotor muscle afferent inhibition on the ventilatory response to exercise in heart failure. Exp Physiol 2014; 99: 414-426.
7. Cahalin LP, Arena R, Guazzi M, Myers J, Cipriano G, Chiappa G, Lavie CJ, Forman DE,. Inspiratory muscle training in heart disease and heart failure: a review of the literature with a focus on method of training and outcomes. Expert Rev Cardiovasc Ther 2013; 11: 161-177.
8. Nymo SH, Hulthe J, Ueland T, McMurray J, Wikstrand J, Askevold ET, Yndestad A, Gullestad L, Aukrust P,. Inflammatory cytokines in chronic heart failure: interleukin-8 is associated with adverse outcome. Results from CORONA. Eur J Heart Fail 2014; 16: 68-75.
9. Gielen S, Adams V, Linke A, Erbs S, Mobius-Winkler S, Schubert A, Schuler G, Hambrecht R,. Exercise training in chronic heart failure: correlation between reduced local inflammation and improved oxidative capacity in the skeletal muscle. Eur J Cardiovasc Prev Rehabil 2005; 12: 393-400.
10. Mangner N, Linke A, Oberbach A, Kullnick Y, Gielen S, Sandri M, Hoellriegel R, Matsumoto Y, Schuler G, Adams V,. Exercise training prevents TNF-alpha induced loss of force in the diaphragm of mice. PLoS One 2013; 8: e52274.
11. Rezk BM, Yoshida T, Semprun-Prieto L, Higashi Y, Sukhanov S, Delafontaine P,. Angiotensin II infusion induces marked diaphragmatic skeletal muscle atrophy. PLoS One 2012; 7: e30276.
12. Nikolova-Karakashian MN, Reid MB,. Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle. Antioxid Redox Signal 2011; 15: 2501-2517.
13. Berry C, Touyz R, Dominiczak AF, Webb RC, Johns DG,. Angiotensin receptors: signaling, vascular pathophysiology, and interactions with ceramide. Am J Physiol Heart Circ Physiol 2001; 281: H2337-H2365.
14. Doehner W, Bunck AC, Rauchhaus M, von Haehling S, Brunkhorst FM, Cicoira M, Tschope C, Ponikowski P, Claus RA, Anker SD,. Secretory sphingomyelinase is upregulated in chronic heart failure: a second messenger system of immune activation relates to body composition, muscular functional capacity, and peripheral blood flow. Eur Heart J 2007; 28: 821-828.
15. Adamy C, Mulder P, Khouzami L, Andrieu-abadie N, Defer N, Candiani G, Pavoine C, Caramelle P, Souktani R, Le Corvoisier P, Perier M, Kirsch M, Damy T, Berdeaux A, Levade T, Thuillez C, Hittinger L, Pecker F,. Neutral sphingomyelinase inhibition participates to the benefits of N-acetylcysteine treatment in post-myocardial infarction failing heart rats. J Mol Cell Cardiol 2007; 43: 344-353.
16. Ferreira LF, Moylan JS, Gilliam LA, Smith JD, Nikolova-Karakashian M, Reid MB,. Sphingomyelinase stimulates oxidant signaling to weaken skeletal muscle and promote fatigue. Am J Physiol Cell Physiol 2010; 299: C552-C560.
17. Ferreira LF, Moylan JS, Stasko S, Smith JD, Campbell KS, Reid MB,. Sphingomyelinase depresses force and calcium sensitivity of the contractile apparatus in mouse diaphragm muscle fibres. J Appl Physiol 2012; 112: 1538-1545.
18. Tikunov BA, Sweeney HL, Rome LC,. Quantitative electrophoretic analysis of myosin heavy chains in single muscle fibres. J Appl Physiol 2001; 90: 1927-1935.
19. Nikolova-Karakashian M, Morgan ET, Alexander C, Liotta DC, Merrill AH Jr,. Bimodal regulation of ceramidase by interleukin-1beta. Implications for the regulation of cytochrome p450 2C11. J Biol Chem 1997; 272: 18718-18724.
20. Bielawski J, Pierce JS, Snider J, Rembiesa B, Szulc ZM, Bielawska A,. Sphingolipid analysis by high performance liquid chromatography-tandem mass spectrometry (HPLC-MS/MS). Adv Exp Med Biol 2010; 688: 46-59.
21. Ahn B, Empinado HM, Al-Rajhi M, Judge AR, Ferreira LF,. Diaphragm atrophy and contractile dysfunction in a murine model of pulmonary hypertension. PLoS One 2013; 8: e62702.
22. Lindsay DC, Lovegrove CA, Dunn MJ, Bennett JG, Pepper JR, Yacoub MH, Poole-Wilson PA,. Histological abnormalities of muscle from limb, thorax and diaphragm in chronic heart failure. Eur Heart J 1996; 17: 1239-1250.
23. Tikunov BA, Mancini D, Levine S,. Changes in myofibrillar protein composition of human diaphragm elicited by congestive heart failure. J Mol Cell Cardiol 1996; 28: 2537-2541.
24. Dalla Libera L, Ravara B, Angelini A, Rossini K, Sandri M, Thiene G, Battista Ambrosio G, Vescovo G,. Beneficial effects on skeletal muscle of the angiotensin II type 1 receptor blocker irbesartan in experimental heart failure. Circulation 2001; 103: 2195-2200.
25. Supinski GS, Callahan LA,. Diaphragmatic free radical generation increases in an animal model of heart failure. J Appl Physiol 2005; 99: 1078-1084.
26. Knapp M, Baranowski M, Lisowska A, Musial W,. Decreased free sphingoid base concentration in the plasma of patients with chronic systolic heart failure. Adv Med Sci 2012; 57: 100-105.
27. Knapp M, Zendzian-Piotrowska M, Blachnio-Zabielska A, Zabielski P, Kurek K, Gorski J,. Myocardial infarction differentially alters sphingolipid levels in plasma, erythrocytes and platelets of the rat. Basic Res Cardiol 2012; 107: 294-309.
28. Zhang QJ, Holland WL, Wilson L, Tanner JM, Kearns D, Cahoon JM, Pettey D, Losee J, Duncan B, Gale D, Kowalski CA, Deeter N, Nichols A, Deesing M, Arrant C, Ruan T, Boehme C, McCamey DR, Rou J, Ambal K, Narra KK, Summers SA, Abel ED, Symons JD,. Ceramide mediates vascular dysfunction in diet-induced obesity by PP2A-mediated dephosphorylation of the eNOS-Akt complex. Diabetes 2012; 61: 1848-1859.
29. Bikman BT, Guan Y, Shui G, Siddique MM, Holland WL, Kim JY, Fabrias G, Wenk MR, Summers SA,. Fenretinide prevents lipid-induced insulin resistance by blocking ceramide biosynthesis. J Biol Chem 2012; 287: 17426-17437.
30. Canals D, Perry DM, Jenkins RW, Hannun YA,. Drug targeting of sphingolipid metabolism: sphingomyelinases and ceramidases. Br J Pharmacol 2011; 163: 694-712.
31. Stoffel W, Jenke B, Block B, Zumbansen M, Koebke J,. Neutral sphingomyelinase 2 (smpd3) in the control of postnatal growth and development. Proc Natl Acad Sci USA 2005; 102: 4554-4559.
32. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Bohm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Kober L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Ronnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S, Bonet LA, Avraamides P, Ben Lamin HA, Brignole M, Coca A, Cowburn P, Dargie H, Elliott P, Flachskampf FA, Guida GF, Hardman S, Iung B, Merkely B, Mueller C, Nanas JN, Nielsen OW, Orn S, Parissis JT, Ponikowski P,. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012; 14: 803-869.
33. Marco E, Ramirez-Sarmiento AL, Coloma A, Sartor M, Comin-Colet J, Vila J, Enjuanes C, Bruguera J, Escalada F, Gea J, Orozco-Levi M,. High-intensity vs. sham inspiratory muscle training in patients with chronic heart failure: a prospective randomized trial. Eur J Heart Fail 2013; 15: 892-901.
34. Danieli-Betto D, Peron S, Germinario E, Zanin M, Sorci G, Franzoso S, Sandona D, Betto R,. Sphingosine 1-phosphate signaling is involved in skeletal muscle regeneration. Am J Physiol Cell Physiol 2010; 298: C550-C558.
35. Danieli-Betto D, Germinario E, Esposito A, Megighian A, Midrio M, Ravara B, Damiani E, Libera LD, Sabbadini RA, Betto R,. Sphingosine 1-phosphate protects mouse extensor digitorum longus skeletal muscle during fatigue. Am J Physiol Cell Physiol 2005; 288: C1367-C1373.
36. Meissner A, Yang J, Kroetsch JT, Sauve M, Dax H, Momen A, Noyan-Ashraf MH, Heximer S, Husain M, Lidington D, Bolz SS,. Tumor necrosis factor-alpha-mediated downregulation of the cystic fibrosis transmembrane conductance regulator drives pathological sphingosine-1-phosphate signaling in a mouse model of heart failure. Circulation 2012; 125: 2739-2750.